GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
GTHX
Delisted
GTHX was delisted on the 17th of September, 2024.
98 hedge funds and large institutions have $98.2M invested in G1 Therapeutics, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 21 increasing their positions, 33 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
47% less capital invested
Capital invested by funds: $184M → $98.2M (-$86M)
Holders
98
Holding in Top 10
–
Calls
$463K
Puts
$161K
Top Buyers
| 1 | +$9.95M | |
| 2 | +$3.34M | |
| 3 | +$2.57M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$2.25M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$2.09M |
Top Sellers
| 1 | -$19.6M | |
| 2 | -$10.7M | |
| 3 | -$4.12M | |
| 4 |
Nordea Investment Management
Stockholm,
Sweden
|
-$3.13M |
| 5 |
Rafferty Asset Management
New York
|
-$1.95M |